Landec Corporation Average Days of Receivables

Average Days of Receivables of LNDC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Average Days of Receivables growth rates and interactive chart.

Highlights and Quick Summary

  • Annual Average Days of Receivables for 2020 was 47.12 (a 0.57% increase from previous year)
  • Annual Average Days of Receivables for 2019 was 46.85 (a 24.89% increase from previous year)
  • Annual Average Days of Receivables for 2018 was 37.51 (a 5.19% increase from previous year)
  • Twelve month Average Days of Receivables ending February 27, 2021 was 45.31 (a 7.38% increase compared to previous quarter)
  • Twelve month trailing Average Days of Receivables decreased by -3.83% year-over-year
Trailing Average Days of Receivables for the last four month:
27 Feb '21 29 Nov '20 30 Aug '20 30 May '20
45.31 42.2 40.41 47.12
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Average Days of Receivables of Landec Corporation

Most recent Average Days of Receivablesof LNDC including historical data for past 10 years.

Interactive Chart of Average Days of Receivables of Landec Corporation

Landec Corporation Average Days of Receivables for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 47.12
2019 46.85
2018 37.51
2017 35.66
2016 31.3
2015 31.46
2014 35.77
2013 34.58
2012 37.15
2011 29.91
2010 30.8

Business Profile of Landec Corporation

Sector: Consumer Defensive
Industry: Packaged Foods
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets. It operates through Curation Foods and Lifecore segments. The Curation Foods segment engages in processing, marketing, and selling of vegetable-based salads, and fresh-cut and whole vegetable products primarily under the Eat Smart brand, O branded olive oils and wine vinegars, and Yucatan and Cabo Fresh guacamole and avocado food products, as well as various private labels. It serves retail grocery chains, club stores, and food service operators. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology transfer, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. It sells its products directly to partners in the medical device and pharmaceutical markets. The company was founded in 1986 and is headquartered in Santa Clara, California.